{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:51:46Z","timestamp":1790391106925,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,3,25]],"date-time":"2016-03-25T00:00:00Z","timestamp":1458864000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81371436, 31070928"],"award-info":[{"award-number":["81371436, 31070928"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China (CN)","doi-asserted-by":"publisher","award":["81171073, 81471149"],"award-info":[{"award-number":["81171073, 81471149"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s12035-016-9871-9","type":"journal-article","created":{"date-parts":[[2016,3,25]],"date-time":"2016-03-25T03:40:04Z","timestamp":1458877204000},"page":"2831-2842","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Epigenetic Downregulation of Scn3a Expression by Valproate: a Possible Role in Its Anticonvulsant Activity"],"prefix":"10.1007","volume":"54","author":[{"given":"Na-Na","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ling","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Wang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Mei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Hua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Hong","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ping","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Sheng","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,25]]},"reference":[{"key":"9871_CR1","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","volume":"46","author":"RS Fisher","year":"2005","unstructured":"Fisher RS, van Emde BW, Blume W, Elger C, Genton P, Lee P, Engel J Jr (2005) Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46:470\u2013472","journal-title":"Epilepsia"},{"key":"9871_CR2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.brainres.2003.11.051","volume":"1000","author":"JP Klein","year":"2004","unstructured":"Klein JP, Khera DS, Nersesyan H, Kimchi EY, Waxman SG, Blumenfeld H (2004) Dysregulation of sodium channel expression in cortical neurons in a rodent model of absence epilepsy. Brain Res 1000:102\u2013109","journal-title":"Brain Res"},{"key":"9871_CR3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/1073858406295832","volume":"13","author":"E Aronica","year":"2007","unstructured":"Aronica E, Gorter JA (2007) Gene expression profile in temporal lobe epilepsy. Neuroscientist 13:100\u2013108","journal-title":"Neuroscientist"},{"key":"9871_CR4","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1523\/JNEUROSCI.5377-03.2004","volume":"24","author":"CA Altar","year":"2004","unstructured":"Altar CA, Laeng P, Jurata LW, Brockman JA, Lemire A, Bullard J, Bukhman YV, Young TA et al (2004) Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J Neurosci 24:2667\u20132677","journal-title":"J Neurosci"},{"key":"9871_CR5","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1002\/j.1460-2075.1989.tb08534.x","volume":"8","author":"S Beckh","year":"1989","unstructured":"Beckh S, Noda M, Lubbert H, Numa S (1989) Differential regulation of three sodium channel messenger RNAs in the rat central nervous system during development. The EMBO J 8:3611\u20133616","journal-title":"The EMBO J"},{"key":"9871_CR6","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/BF00230529","volume":"86","author":"W Brysch","year":"1991","unstructured":"Brysch W, Creutzfeldt OD, Luno K, Schlingensiepen R, Schlingensiepen KH (1991) Regional and temporal expression of sodium channel messenger RNAs in the rat brain during development. Exp Brain Res 86:562\u2013567","journal-title":"Exp Brain Res"},{"key":"9871_CR7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0169-328X(00)00289-8","volume":"88","author":"WR Whitaker","year":"2001","unstructured":"Whitaker WR, Faull RL, Waldvogel HJ, Plumpton CJ, Emson PC, Clare JJ (2001) Comparative distribution of voltage-gated sodium channel proteins in human brain. Brain Res 88:37\u201353","journal-title":"Brain Res"},{"key":"9871_CR8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.brainresbull.2007.10.005","volume":"75","author":"F Guo","year":"2008","unstructured":"Guo F, Yu N, Cai JQ, Quinn T, Zong ZH, Zeng YJ, Hao LY (2008) Voltage-gated sodium channel Nav1.1, Nav1.3 and beta1 subunit were up-regulated in the hippocampus of spontaneously epileptic rat. Brain Res Bull 75:179\u2013187","journal-title":"Brain Res Bull"},{"key":"9871_CR9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/WNR.0b013e328351db48","volume":"23","author":"S Yu","year":"2012","unstructured":"Yu S, Li S, Shu H, Zhang C, He J, Fan X, Yang H (2012) Upregulated expression of voltage-gated sodium channel Nav1.3 in cortical lesions of patients with focal cortical dysplasia type IIb. Neuroreport 23:407\u2013411","journal-title":"Neuroreport"},{"key":"9871_CR10","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1523\/JNEUROSCI.4139-03.2004","volume":"24","author":"C Chen","year":"2004","unstructured":"Chen C, Westenbroek RE, Xu X, Edwards CA, Sorenson DR, Chen Y, McEwen DP, O\u2019Malley HA et al (2004) Mice lacking sodium channel beta1 subunits display defects in neuronal excitability, sodium channel expression, and nodal architecture. J Neurosci 24:4030\u20134042","journal-title":"J Neurosci"},{"key":"9871_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbagrm.2014.11.004","volume":"1849","author":"HJ Li","year":"2015","unstructured":"Li HJ, Wan RP, Tang LJ, Liu SJ, Zhao QH, Gao MM, Yi YH, Liao WP et al (2015) Alteration of Scn3a expression is mediated via CpG methylation and MBD2 in mouse hippocampus during postnatal development and seizure condition. Biochimica et Biophysica Acta 1849:1\u20139","journal-title":"Biochimica et Biophysica Acta"},{"key":"9871_CR12","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.1523\/JNEUROSCI.21-16-05952.2001","volume":"21","author":"TR Cummins","year":"2001","unstructured":"Cummins TR, Aglieco F, Renganathan M, Herzog RI, Dib-Hajj SD, Waxman SG (2001) Nav1.3 sodium channels: rapid repriming and slow closed-state inactivation display quantitative differences after expression in a mammalian cell line and in spinal sensory neurons. J Neurosci 21:5952\u20135961","journal-title":"J Neurosci"},{"key":"9871_CR13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1059-1311(00)90530-2","volume":"10","author":"S Calleja","year":"2001","unstructured":"Calleja S, Salas-Puig J, Ribacoba R, Lahoz CH (2001) Evolution of juvenile myoclonic epilepsy treated from the outset with sodium valproate. Seizure 10:424\u2013427","journal-title":"Seizure"},{"key":"9871_CR14","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.0013-9580.2004.40903.x","volume":"45","author":"G Coppola","year":"2004","unstructured":"Coppola G, Auricchio G, Federico R, Carotenuto M, Pascotto A (2004) Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study. Epilepsia 45:1049\u20131053","journal-title":"Epilepsia"},{"key":"9871_CR15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1528-1157.1988.tb04409.x","volume":"29","author":"JC Dean","year":"1988","unstructured":"Dean JC, Penry JK (1988) Valproate monotherapy in 30 patients with partial seizures. Epilepsia 29:140\u2013144","journal-title":"Epilepsia"},{"key":"9871_CR16","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archpedi.1982.03970420050011","volume":"136","author":"G Erenberg","year":"1960","unstructured":"Erenberg G, Rothner AD, Henry CE (1960) Cruse RP (1982) Valproic acid in the treatment of intractable absence seizures in children: a single-blind clinical and quantitative EEG study. Am J Dis Child 136:526\u2013529","journal-title":"Am J Dis Child"},{"key":"9871_CR17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0163-7258(02)00299-1","volume":"96","author":"N Gurvich","year":"2002","unstructured":"Gurvich N, Klein PS (2002) Lithium and valproic acid: parallels and contrasts in diverse signaling contexts. Pharmacol Ther 96:45\u201366","journal-title":"Pharmacol Ther"},{"key":"9871_CR18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.mehy.2004.07.019","volume":"64","author":"M Toth","year":"2005","unstructured":"Toth M (2005) The epsilon theory: a novel synthesis of the underlying molecular and electrophysiological mechanisms of primary generalized epilepsy and the possible mechanism of action of valproate. Med hypotheses 64:267\u2013272","journal-title":"Med hypotheses"},{"key":"9871_CR19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0197-0186(00)00013-9","volume":"37","author":"CU Johannessen","year":"2000","unstructured":"Johannessen CU (2000) Mechanisms of action of valproate: a commentatory. Neurochem Int 37:103\u2013110","journal-title":"Neurochem Int"},{"key":"9871_CR20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-0082(98)00075-6","volume":"58","author":"W Loscher","year":"1999","unstructured":"Loscher W (1999) Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Prog Neurobiol 58:31\u201359","journal-title":"Prog Neurobiol"},{"key":"9871_CR21","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","volume":"20","author":"M Gottlicher","year":"2001","unstructured":"Gottlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, Giavara S, Sleeman JP, Lo Coco F et al (2001) Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 20:6969\u20136978","journal-title":"EMBO J"},{"key":"9871_CR22","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","volume":"276","author":"CJ Phiel","year":"2001","unstructured":"Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS (2001) Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276:36734\u201336741","journal-title":"J Biol Chem"},{"key":"9871_CR23","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/carcin\/bgl167","volume":"28","author":"S Milutinovic","year":"2007","unstructured":"Milutinovic S, D\u2019Alessio AC, Detich N, Szyf M (2007) Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes. Carcinogenesis 28:560\u2013571","journal-title":"Carcinogenesis"},{"key":"9871_CR24","doi-asserted-by":"crossref","first-page":"40778","DOI":"10.1074\/jbc.M103921200","volume":"276","author":"N Cervoni","year":"2001","unstructured":"Cervoni N, Szyf M (2001) Demethylase activity is directed by histone acetylation. J Biol Chem 276:40778\u201340787","journal-title":"J Biol Chem"},{"key":"9871_CR25","doi-asserted-by":"crossref","first-page":"25026","DOI":"10.1074\/jbc.M202256200","volume":"277","author":"N Cervoni","year":"2002","unstructured":"Cervoni N, Detich N, Seo SB, Chakravarti D, Szyf M (2002) The oncoprotein Set\/TAF-1beta, an inhibitor of histone acetyltransferase, inhibits active demethylation of DNA, integrating DNA methylation and transcriptional silencing. J Biol Chem 277:25026\u201325031","journal-title":"J Biol Chem"},{"key":"9871_CR26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0169-328X(98)00107-7","volume":"58","author":"V Asghari","year":"1998","unstructured":"Asghari V, Wang JF, Reiach JS, Young LT (1998) Differential effects of mood stabilizers on Fos\/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY5Y cells. Brain Res 58:95\u2013102","journal-title":"Brain Res"},{"key":"9871_CR27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0169-328X(98)00303-9","volume":"64","author":"G Chen","year":"1999","unstructured":"Chen G, Yuan PX, Jiang YM, Huang LD, Manji HK (1999) Valproate robustly enhances AP-1 mediated gene expression. Brain Res 64:52\u201358","journal-title":"Brain Res"},{"key":"9871_CR28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neures.2009.05.002","volume":"65","author":"M Fukuchi","year":"2009","unstructured":"Fukuchi M, Nii T, Ishimaru N, Minamino A, Hara D, Takasaki I, Tabuchi A, Tsuda M (2009) Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions. Neurosci Res 65:35\u201343","journal-title":"Neurosci Res"},{"key":"9871_CR29","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/epi.12745","volume":"55","author":"SJ Petty","year":"2014","unstructured":"Petty SJ, Kantor S, Lawrence KM, Berkovic SF, Collins M, Hill KD, Makovey J, Sambrook PN et al (2014) Weight and fat distribution in patients taking valproate: a valproate-discordant gender-matched twin and sibling pair study. Epilepsia 55:1551\u20131557","journal-title":"Epilepsia"},{"key":"9871_CR30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1469-8749.2009.03402.x","volume":"52","author":"M Rauchenzauner","year":"2010","unstructured":"Rauchenzauner M, Griesmacher A, Tatarczyk T, Haberlandt E, Strasak A, Zimmerhackl LB, Falkensammer G, Luef G et al (2010) Chronic antiepileptic monotherapy, bone metabolism, and body composition in non-institutionalized children. Dev Med Child Neurol 52:283\u2013288","journal-title":"Dev Med Child Neurol"},{"key":"9871_CR31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejphar.2013.09.024","volume":"721","author":"L Zhang","year":"2013","unstructured":"Zhang L, Chu X, Wang H, Xie H, Guo C, Cao L, Zhou X, Wang G et al (2013) Dysregulations of UDP-glucuronosyltransferases in rats with valproic acid and high fat diet induced fatty liver. Eur J Pharmacol 721:277\u2013285","journal-title":"Eur J Pharmacol"},{"key":"9871_CR32","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/ng.713","volume":"42","author":"C Church","year":"2010","unstructured":"Church C, Moir L, McMurray F, Girard C, Banks GT, Teboul L, Wells S, Bruning JC et al (2010) Overexpression of Fto leads to increased food intake and results in obesity. Nat Genet 42:1086\u20131092","journal-title":"Nat Genet"},{"key":"9871_CR33","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature07848","volume":"458","author":"J Fischer","year":"2009","unstructured":"Fischer J, Koch L, Emmerling C, Vierkotten J, Peters T, Bruning JC, Ruther U (2009) Inactivation of the Fto gene protects from obesity. Nature 458:894\u2013898","journal-title":"Nature"},{"key":"9871_CR34","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1523\/JNEUROSCI.5180-11.2012","volume":"32","author":"SF Miller-Delaney","year":"2012","unstructured":"Miller-Delaney SF, Das S, Sano T, Jimenez-Mateos EM, Bryan K, Buckley PG, Stallings RL, Henshall DC (2012) Differential DNA methylation patterns define status epilepticus and epileptic tolerance. J Neurosci 32:1577\u20131588","journal-title":"J Neurosci"},{"key":"9871_CR35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature13138","volume":"507","author":"S Smemo","year":"2014","unstructured":"Smemo S, Tena JJ, Kim KH, Gamazon ER, Sakabe NJ, Gomez-Marin C, Aneas I, Credidio FL et al (2014) Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature 507:371\u2013375","journal-title":"Nature"},{"key":"9871_CR36","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nature11401","volume":"490","author":"J Yang","year":"2012","unstructured":"Yang J, Loos RJ, Powell JE, Medland SE, Speliotes EK, Chasman DI, Rose LM, Thorleifsson G et al (2012) FTO genotype is associated with phenotypic variability of body mass index. Nature 490:267\u2013272","journal-title":"Nature"},{"key":"9871_CR37","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1126\/science.1151710","volume":"318","author":"T Gerken","year":"2007","unstructured":"Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V, Hewitson KS, Yeo GS, McDonough MA et al (2007) The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 318:1469\u20131472","journal-title":"Science"},{"key":"9871_CR38","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nchembio.687","volume":"7","author":"G Jia","year":"2012","unstructured":"Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y, Yi C, Lindahl T et al (2012) N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nature Chem Biol 7:885\u2013887","journal-title":"Nature Chem Biol"},{"key":"9871_CR39","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.4161\/epi.21977","volume":"7","author":"J Rowles","year":"2012","unstructured":"Rowles J, Wong M, Powers R, Olsen M (2012) FTO, RNA epigenetics and epilepsy. Epigenetics 7:1094\u20131097","journal-title":"Epigenetics"},{"issue":"Suppl","key":"9871_CR40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/ng1089","volume":"33","author":"R Jaenisch","year":"2003","unstructured":"Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33(Suppl):245\u2013254","journal-title":"Nat Genet"},{"key":"9871_CR41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.55782\/ane-2013-1919","volume":"73","author":"M Gos","year":"2013","unstructured":"Gos M (2013) Epigenetic mechanisms of gene expression regulation in neurological diseases. Acta Neurobiol Exp 73:19\u201337","journal-title":"Acta Neurobiol Exp"},{"key":"9871_CR42","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nm.2828","volume":"18","author":"M Jakovcevski","year":"2012","unstructured":"Jakovcevski M, Akbarian S (2012) Epigenetic mechanisms in neurological disease. Nat Med 18:1194\u20131204","journal-title":"Nat Med"},{"key":"9871_CR43","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S1474-4422(09)70262-5","volume":"8","author":"RG Urdinguio","year":"2009","unstructured":"Urdinguio RG, Sanchez-Mut JV, Esteller M (2009) Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol 8:1056\u20131072","journal-title":"Lancet Neurol"},{"key":"9871_CR44","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/NEN.0b013e31819ba737","volume":"68","author":"K Kobow","year":"2009","unstructured":"Kobow K, Jeske I, Hildebrandt M, Hauke J, Hahnen E, Buslei R, Buchfelder M, Weigel D et al (2009) Increased reelin promoter methylation is associated with granule cell dispersion in human temporal lobe epilepsy. J Neuropathol Exp Neurol 68:356\u2013364","journal-title":"J Neuropathol Exp Neurol"},{"key":"9871_CR45","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1523\/JNEUROSCI.5516-05.2006","volume":"26","author":"C Heinrich","year":"2006","unstructured":"Heinrich C, Nitta N, Flubacher A, Muller M, Fahrner A, Kirsch M, Freiman T, Suzuki F et al (2006) Reelin deficiency and displacement of mature neurons, but not neurogenesis, underlie the formation of granule cell dispersion in the epileptic hippocampus. J Neurosci 26:4701\u20134713","journal-title":"J Neurosci"},{"key":"9871_CR46","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1124\/mol.106.030635","volume":"71","author":"M Kundakovic","year":"2007","unstructured":"Kundakovic M, Chen Y, Costa E, Grayson DR (2007) DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes. Mol Pharmacol 71:644\u2013653","journal-title":"Mol Pharmacol"},{"key":"9871_CR47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuropharm.2015.06.018","volume":"99","author":"D Balasubramanian","year":"2015","unstructured":"Balasubramanian D, Deng AX, Doudney K, Hampton MB, Kennedy MA (2015) Valproic acid exposure leads to upregulation and increased promoter histone acetylation of sepiapterin reductase in a serotonergic cell line. Neuropharmacology 99:79\u201388","journal-title":"Neuropharmacology"},{"key":"9871_CR48","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12031-011-9492-8","volume":"44","author":"GF Deng","year":"2011","unstructured":"Deng GF, Qin JM, Sun XS, Kuang ZY, Su T, Zhao QH, Shi YW, Liu XR et al (2011) Promoter analysis of mouse Scn3a gene and regulation of the promoter activity by GC box and CpG methylation. J Mol Neurosci 44:115\u2013121","journal-title":"J Mol Neurosci"},{"key":"9871_CR49","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bcp.2004.04.013","volume":"68","author":"M Michaelis","year":"2004","unstructured":"Michaelis M, Kohler N, Reinisch A, Eikel D, Gravemann U, Doerr HW, Nau H, Cinatl J Jr (2004) Increased human cytomegalovirus replication in fibroblasts after treatment with therapeutical plasma concentrations of valproic acid. Biochem Pharmacol 68:531\u2013538","journal-title":"Biochem Pharmacol"},{"key":"9871_CR50","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","volume":"16","author":"W Loscher","year":"2002","unstructured":"Loscher W (2002) Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy. CNS drugs 16:669\u2013694","journal-title":"CNS drugs"},{"key":"9871_CR51","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","volume":"16","author":"E Perucca","year":"2002","unstructured":"Perucca E (2002) Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS drugs 16:695\u2013714","journal-title":"CNS drugs"},{"key":"9871_CR52","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0022-3565(25)24966-7","volume":"237","author":"MJ McLean","year":"1986","unstructured":"McLean MJ, Macdonald RL (1986) Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture. J Pharmacol Exp Ther 237:1001\u20131011","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 2","key":"9871_CR53","first-page":"17","volume":"37","author":"MJ Owens","year":"2003","unstructured":"Owens MJ, Nemeroff CB (2003) Pharmacology of valproate. Psychopharmacol Bull 37(Suppl 2):17\u201324","journal-title":"Psychopharmacol Bull"},{"key":"9871_CR54","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4161\/epi.5.8.13053","volume":"5","author":"E Dong","year":"2010","unstructured":"Dong E, Chen Y, Gavin DP, Grayson DR, Guidotti A (2010) Valproate induces DNA demethylation in nuclear extracts from adult mouse brain. Epigenetics 5:730\u2013735","journal-title":"Epigenetics"},{"key":"9871_CR55","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00213-006-0317-3","volume":"185","author":"G Gobbi","year":"2006","unstructured":"Gobbi G, Janiri L (2006) Sodium- and magnesium-valproate in vivo modulate glutamatergic and GABAergic synapses in the medial prefrontal cortex. Psychopharmacology 185:255\u2013262","journal-title":"Psychopharmacology"},{"key":"9871_CR56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.nbd.2010.02.005","volume":"39","author":"IA Qureshi","year":"2010","unstructured":"Qureshi IA, Mehler MF (2010) Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis. Neurobiol Dis 39:53\u201360","journal-title":"Neurobiol Dis"},{"key":"9871_CR57","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev-pharmtox-061008-103102","volume":"49","author":"M Szyf","year":"2009","unstructured":"Szyf M (2009) Epigenetics, DNA methylation, and chromatin modifying drugs. Annu Rev Pharmacol Toxicol 49:243\u2013263","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"9871_CR58","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJM199209103271104","volume":"327","author":"RH Mattson","year":"1992","unstructured":"Mattson RH, Cramer JA, Collins JF (1992) A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. N Engl J Med 327:765\u2013771","journal-title":"N Engl J Med"},{"key":"9871_CR59","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1212\/WNL.51.4.1018","volume":"51","author":"F Gilliam","year":"1998","unstructured":"Gilliam F, Vazquez B, Sackellares JC, Chang GY, Messenheimer J, Nyberg J, Risner ME, Rudd GD (1998) An active-control trial of lamotrigine monotherapy for partial seizures. Neurology 51:1018\u20131025","journal-title":"Neurology"},{"issue":"Suppl 1","key":"9871_CR60","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1177\/088307380502000101","volume":"20","author":"JW Wheless","year":"2005","unstructured":"Wheless JW, Clarke DF, Carpenter D (2005) Treatment of pediatric epilepsy: expert opinion, 2005. J Child Neurol 20(Suppl 1):S1\u201356; quiz S59-60","journal-title":"J Child Neurol"},{"key":"9871_CR61","doi-asserted-by":"crossref","first-page":"224","DOI":"10.5603\/EP.2014.0031","volume":"65","author":"A Zdrojowy-Welna","year":"2014","unstructured":"Zdrojowy-Welna A, Tupikowska M, Kolackov K, Bednarek-Tupikowska G (2014) The role of fat mass and obesity-associated gene (FTO) in obesity\u2014an overview. Endokrynol Pol 65:224\u2013231","journal-title":"Endokrynol Pol"},{"key":"9871_CR62","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0028-3908(02)00400-8","volume":"44","author":"G Liu","year":"2003","unstructured":"Liu G, Yarov-Yarovoy V, Nobbs M, Clare JJ, Scheuer T, Catterall WA (2003) Differential interactions of lamotrigine and related drugs with transmembrane segment IVS6 of voltage-gated sodium channels. Neuropharmacology 44:413\u2013422","journal-title":"Neuropharmacology"},{"key":"9871_CR63","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/adc.2009.176990","volume":"96","author":"C Cummings","year":"2011","unstructured":"Cummings C, Stewart M, Stevenson M, Morrow J, Nelson J (2011) Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine. Arch Dis Child 96:643\u2013647","journal-title":"Arch Dis Child"},{"issue":"Suppl 9","key":"9871_CR64","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/epi.12030","volume":"53","author":"A Roopra","year":"2012","unstructured":"Roopra A, Dingledine R, Hsieh J (2012) Epigenetics and epilepsy. Epilepsia 53(Suppl 9):2\u201310","journal-title":"Epilepsia"},{"key":"9871_CR65","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","volume":"149","author":"KD Meyer","year":"2012","unstructured":"Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR (2012) Comprehensive analysis of mRNA methylation reveals enrichment in 3\u2032 UTRs and near stop codons. Cell 149:1635\u20131646","journal-title":"Cell"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-016-9871-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-9871-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-9871-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-9871-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T23:38:37Z","timestamp":1748821117000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-016-9871-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,25]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["9871"],"URL":"https:\/\/doi.org\/10.1007\/s12035-016-9871-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,25]]}}}